Okay, let's tackle this question. The patient has limited systemic sclerosis (scleroderma) and has had it for 10 years. The main symptom is shortness of breath for a year. The PFTs show FVC is slightly reduced (2.63 vs 2.82 predicted), FEV1 is 88% of predicted, which is normal, and DLCO is 5.2 vs 16.3 predicted.

First, systemic sclerosis can affect the lungs in a few ways. The two main issues are interstitial lung disease (like pulmonary fibrosis) and pulmonary arterial hypertension. But the PFTs here show a restrictive pattern if FVC is reduced with normal FEV1/FVC ratio. However, FVC is only slightly reduced, and FEV1 is normal. The DLCO is severely reduced, which is a key point. DLCO measures the diffusion capacity of the lungs, primarily reflecting the alveolar-capillary membrane. A low DLCO suggests interstitial lung disease because the thickened alveolar walls reduce gas transfer. Alternatively, pulmonary vascular disease (like PAH) can also lower DLCO, but PAH is more associated with normal or near-normal DLCO in early stages, and later it might decrease. But with systemic sclerosis, interstitial lung disease is common, so that's probably the cause here.

Looking at the options, the probable diagnosis is interstitial lung disease (like pulmonary fibrosis). The other options might include asthma (but FEV1 is normal, and DLCO is low), COPD (but FEV1/FVC is normal here), or maybe pulmonary hypertension. But given the DLCO is so low, interstitial disease is more likely.

Wait, the question didn't list the options. Oh, the user didn't provide them. But the correct answer was supposed to be one of the options. Assuming that one of the options is interstitial lung disease or pulmonary fibrosis. Since DLCO is the most significant finding here, that's a classic sign of ILD. So the answer would be interstitial lung disease related to systemic sclerosis.

**Core Concept**
Systemic sclerosis (scleroderma) commonly causes interstitial lung disease (ILD) due to fibroblast activation and collagen deposition in lung interstitium. DLCO (diffusing capacity of the lungs for carbon monoxide) is a **sensitive marker** of ILD, reflecting alveolar-capillary membrane integrity. A severely reduced DLCO (<50% predicted) with normal FEV1/FVC ratio points to restrictive lung disease. **Why the Correct Answer is Right** The patient’s PFTs show a **normal FEV1** (88% predicted) and **severely reduced DLCO** (32% predicted), consistent with **interstitial lung disease**. In ILD, inflammation and fibrosis thicken the alveolar membrane, impairing gas exchange and reducing DLCO. The mild reduction in FVC (93% predicted) suggests early or mild restrictive involvement. Systemic sclerosis is strongly associated with ILD (up to 50% of patients), making this the most likely diagnosis. **Why Each Wrong Option is Incorrect** **Option A:** *Asthma* causes variable airflow obstruction (FEV1 < FVC reduction) and normal DLCO.

✓ Correct Answer: B. Pulmonary hypeension